Novel multi target-directed ligands targeting 5-HT4 receptors with in cellulo antioxidant properties as promising leads in Alzheimer's disease-Reference-Cited by-同舟云学术

Novel multi target-directed ligands targeting 5-HT4 receptors with in cellulo antioxidant properties as promising leads in Alzheimer's disease

Published:2019-11 Issue: Volume:182 Page:111596
ISSN:0223-5234
Container-title:European Journal of Medicinal Chemistry
language:en
Short-container-title:European Journal of Medicinal Chemistry

Author:

Lanthier Caroline^ORCID,Payan Hugo,Liparulo Irene,Hatat Bérénice,Lecoutey Cédric,Since Marc,Davis Audrey,Bergamini Christian,Claeysen Sylvie^ORCID,Dallemagne Patrick^ORCID,Bolognesi Maria-Laura^ORCID,Rochais Christophe^ORCID

Funder

Fondation Plan Alzheimer

Publisher

Elsevier BV

Subject

Organic Chemistry,Drug Discovery,Pharmacology,General Medicine

Reference50 articles.

1. World Alzheimer Report 2015 the Global Impact of Dementia an Analysis of Prevalence, Incidence, Cost and Trends;Martin Prince,2015

2. Synaptic impairment in Alzheimer's disease: a dysregulated symphony;Forner;Trends Neurosci.,2017

3. Alzheimer's disease: from pathology to therapeutic approaches;Jakob-Roetne;Angew Chem. Int. Ed. Engl.,2009

4. Oxidative stress, synaptic dysfunction, and Alzheimer's disease;Tonnies;J. Alzheimer's Dis.,2017

5. Oxidative stress and the amyloid beta peptide in Alzheimer's disease;Cheignon;Redox Biol.,2018

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development of Pleiotropic TrkB and 5-HT4 Receptor Ligands as Neuroprotective Agents;Molecules;2024-01-19

2. Piperidine Nucleus as a Promising Scaffold for Alzheimer’s Disease: Current Landscape and Future Perspective;Current Topics in Medicinal Chemistry;2023-05

3. 30th Annual GP2A Medicinal Chemistry Conference;Pharmaceuticals;2023-03-12

4. Multi-Target-Directed Ligand Approach in Anti-Alzheimer’s Drug Discovery;Deciphering Drug Targets for Alzheimer’s Disease;2023

5. Design, synthesis, and biological evaluation of novel (4-(1,2,4-oxadiazol-5-yl)phenyl)-2-aminoacetamide derivatives as multifunctional agents for the treatment of Alzheimer's disease;European Journal of Medicinal Chemistry;2022-01